Oncology & Cancer
Vitamin C as a treatment for cancer—the evidence so far
If a headline says research shows a diet rich in a food 'could help fight cancer' then our advice would be to read on with a critical eye.
Apr 25, 2018
0
4
Cancer Cell
Oncology & Cancer
The key to stopping sarcomas' spread
When sarcomas become large enough and outgrow their blood supply, they become vulnerable to hypoxia—a lack of oxygen. That adaptation not only enables them to survive the stress of low oxygen—it also enables them to withstand ...
May 12, 2015
0
5
Oncology & Cancer
Cancer patients with poor antibody response to COVID-19 vaccines also lack secondary immune response
Patients with the blood cancer multiple myeloma often mount a poor antibody response to COVID-19 vaccines. Mount Sinai researchers have now discovered that these patients also have a weak response from a different part of ...
Oct 19, 2021
0
15
Oncology & Cancer
Blocking epigenetic Swiss army knife may be a new strategy for treating colorectal cancer
A new study out today in Cancer Cell shows that blocking specific regions of a protein called UHRF1 switches on hundreds of cancer-fighting genes, impairing colorectal cancer cells' ability to grow and spread throughout the ...
Apr 4, 2019
0
60
Oncology & Cancer
Cancer that spreads to the lung maneuvers to avoid being attacked by 'killer' T cells
Cancer that has spread to areas like the lungs can apply the brakes to a natural pathway that should recruit killer T cells directly to where it has metastasized, scientists report.
Mar 28, 2023
0
48
Oncology & Cancer
Protein analysis uncovers new cancer subtypes for medulloblastoma
Two patients with the same kind of tumor can have very different experiences. One patient's cancer may progress quickly while the other grows slowly. Treatments may shrink tumors or have no effect at all. And some patients ...
Sep 11, 2018
0
14
Oncology & Cancer
Lasting tumor regression of leukemia and lymphoma in mouse models achieved by U-M compound
For decades, a transcription factor known as STAT3 has been a major therapeutic target in the treatment of cancer. But STAT3 has largely been considered "undruggable" due to the difficulty of developing compounds to effectively ...
Nov 11, 2019
0
265
Oncology & Cancer
Integrated analysis finds vulnerabilities to target in a high-risk pediatric tumor
St. Jude Children's Research Hospital investigators have completed the most comprehensive analysis yet of a common pediatric solid tumor, identifying weaknesses to target and a promising precision medicine that is now in ...
Aug 23, 2018
0
8
Immunology
Study identifies cellular interactions essential to the immune attack on ovarian tumors
A Ludwig Cancer Research study has uncovered a cellular interaction that is essential to the ability of the immune system's cytotoxic T lymphocytes to destroy ovarian tumors and shown that its engagement could help determine ...
Nov 6, 2021
0
78
Oncology & Cancer
Obesity-associated protein could be linked to leukemia development
Cancer researchers at the University of Cincinnati (UC) College of Medicine have found an obesity-associated protein's role in leukemia development and drug response which could lead to more effective therapies for the illness.
Dec 22, 2016
0
1
